Nisha S. Joseph

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar et al. · Journal of Clinical Oncology · 2020 · 231 citations · Full text

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Timothy M. Schmidt, Benjamin G. Barwick, Nisha S. Joseph et al. · Blood Cancer Journal · 2019 · 163 citations · Full text

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re‐treatment with daratumumab among refractory patients

Ajay K. Nooka, Nisha S. Joseph, Jonathan L. Kaufman et al. · Cancer · 2019 · 91 citations · Full text

Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression

Vikas A. Gupta, Benjamin G. Barwick, Shannon M. Matulis et al. · Blood · 2021 · 78 citations · Full text

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents

Roberto Mina, Nisha S. Joseph, Jonathan L. Kaufman et al. · Cancer · 2018 · 55 citations · Full text